Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Corporate Insiders Are Excited About These 3 Stocks

We can now refocus our attention on Campus Crest Communities Inc. (NYSE:CCG), which has seen three different insiders purchase stock so far this week. President and Chief Investment Officer Aaron Scott Halfacre reported buying 10,000 shares on Tuesday at a weighted average price of $6.61, lifting his overall holdings to 166,250 shares. Director Curtis B. McWilliams snapped up 10,000 shares on the same day at prices in the range of $6.61-to-$6.64 per share. The Director currently holds exactly 17,000 shares. Raymond C. Mikulich, another Member of the company’s Board of Directors, acquired 18,913 shares on Monday and 10,000 shares on Tuesday at prices between $6.61 and $6.63, and currently owns 61,900 units of common stock.

In mid-October, the REIT announced a merger agreement with Harrison Street Real Estate Capital LLC, under which Harrison Street is set to purchase all shares of Campus Crest for approximately $7.02 per share. This sale price includes the net sale proceeds of roughly $0.12 per share from a separate sale of its ownership interest in its Evo Montreal joint venture. Thus, it might be the case that these insiders are confident in the success of the merger and believe they will benefit from the discrepancy between the current share price and sale price of the stock. Derek C. Schrier’s Indaba Capital Management was the largest shareholder of Campus Crest Communities Inc. (NYSE:CCG) within our database at the end of the third quarter, holding 5.93 million shares.

Stage Stores Inc. (NYSE:SSI) has seen six different insiders acquire stock in the past several days, so let’s lay out the most noteworthy purchases. To start with, President and Chief Executive Officer Michael L. Glazer bought a 20,000-share block on Friday at a weighted average cost of $6.14, winching up his stake to 402,994 shares. Chairman William J. Montgoris added 10,000 shares, which were acquired at a price of $6.25 per share to his position that now comprises 86,834 shares. Director Ralph P. Scozzafava also purchased 10,000 shares on Friday at a weighted average price of $6.08 and currently holds 34,987 shares. Elaine D. Crowley, another Director of Stage Stores, bought 10,000 shares at prices ranging from $6.83-to-$6.84, lifting up her position to 20,799 shares. Last but not least, Director Alan J. Barocas grabbed 7,500 shares on Monday at a weighted average price of $6.90 and currently owns a 60,894-share stake. This insider bullishness comes after the department store reported disappointing third quarter financial results, which sent the stock plummeting by more than 25% (read more details). The stock is down by 64% for the year, so these insiders are either attempting to put a concerted halt to the recent sell-off or are confident that they will obtain long-term gains from the beaten-down stock.  Steve Cohen’s Point72 Asset Management acquired a 210,100-share stake in Stage Stores Inc. (NYSE:SSI) during the September quarter.

Follow Stage Stores Inc (NYSE:SSI)
Trade (NYSE:SSI) Now!

Disclosure: None

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.